Dr. Ali El Atat, MD

Dr. El Atat practices at A Atat Progressive Pulmonary & Sleep Medicine in Brooklyn, New York.

Dr. El Atat's NPI, 1487853008, was assigned on July 13, 2007. Dr. El Atat graduated from American University of Beirut Faculty of Medicine in 2000. Dr. El Atat holds New York license 271341.

Dr. El Atat's primary practice is A Atat Progressive Pulmonary & Sleep Medicine, at 9001 Ft Hamilton Pkwy, Brooklyn, NY 11209. The practice phone is (718) 748-4446.

Dr. El Atat's primary practice is A Atat Progressive Pulmonary & Sleep Medicine in Brooklyn, New York. Dr. El Atat is also affiliated with Tisch Hospital. The medical group on file is A Atat Progressive Pulmonary & Sleep Medicine. Dmand AI also links Dr. El Atat to 1 more hospital, 3 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. El Atat practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. El Atat's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. El Atat is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. El Atat's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists acid reflux, acute gastroduodenitis, acute respiratory failure, acute sinusitis, acute skin infection, anemia, anxiety and asthma among the conditions Dr. El Atat treats.

CMS data shows 5,014 Medicare services from Dr. El Atat across 22 procedure codes in 2024, for 315 Medicare patients. Medicare paid $190,168 for them.

CMS counts 315 Medicare patients who saw Dr. El Atat in 2024. The largest group is 65 to 74, with 137 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. El Atat's median patient age at 56, with 47% women.

In 2024, Dr. El Atat wrote 12,285 Medicare Part D claims for 724 patients. 72% of them were for generic drugs. CMS names the drug for 11,623 of them, across 137 drugs with 11 or more claims each, at $4,731,376 in total drug cost. In 2023, CMS named 12,209 claims across 133 drugs.

CMS lists Dr. El Atat as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. El Atat to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Asthma and Respiratory Hypersensitivity.

CMS Open Payments shows 1,616 general payments to Dr. El Atat from 53 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 88% of the total. AstraZeneca Pharmaceuticals LP paid the most, $303,483.

Dmand AI lists 2 awards for Dr. El Atat, most recently the leading physician of the world in 2017.

Dr. El Atat graduated from American University of Beirut Faculty of Medicine in 2000.

Dr. El Atat is in network with 16 carriers, including Elevance, Aetna and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.